Search research articles
Contact Us
Filters
Showing results (21-30 of 25) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 25 results.
HIV Medicine
|
May 28, 2025
Comparison of treatment-emergent resistance-associated mutations and discontinuation due to adverse events among integrase strand transfer inhibitor-based single-tablet regimens and cabotegravir + rilpivirine for the treatment of virologically suppressed people with HIV: A systematic literature review and network meta-analysis
Ishfaq Rashid, Nathan R Unger, Connor Willis, et al.
Pharmacotherapy
|
March 20, 2023
Personalizing prevention: Advances in pharmacotherapy for HIV prevention
Marisa Brizzi, Elizabeth M Sherman, Sarah B Green, et al.
Journal of Comparative Effectiveness Research
|
May 28, 2026
Comparative safety of B/F/TAF versus other antiretroviral therapy regimens for treatment-experienced people with HIV-1: a systematic literature review and network meta-analysis
Tristan Curteis, Lucy A Eddowes, Andrei Karlsson, et al.
Pharmacotherapy
|
July 15, 2024
Consensus recommendations for use of long-acting antiretroviral medications in the treatment and prevention of HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases Pharmacists
Elizabeth M Sherman, Allison L Agwu, Juan Ambrosioni, et al.
Pharmacotherapy
|
July 15, 2024
Consensus recommendations for use of long-acting antiretroviral medications in the treatment and prevention of HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases Pharmacists: An executive summary
Elizabeth M Sherman, Allison L Agwu, Juan Ambrosioni, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 25) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 25 results.
HIV Medicine
|
May 28, 2025
Comparison of treatment-emergent resistance-associated mutations and discontinuation due to adverse events among integrase strand transfer inhibitor-based single-tablet regimens and cabotegravir + rilpivirine for the treatment of virologically suppressed people with HIV: A systematic literature review and network meta-analysis
Ishfaq Rashid, Nathan R Unger, Connor Willis, et al.
Pharmacotherapy
|
March 20, 2023
Personalizing prevention: Advances in pharmacotherapy for HIV prevention
Marisa Brizzi, Elizabeth M Sherman, Sarah B Green, et al.
Journal of Comparative Effectiveness Research
|
May 28, 2026
Comparative safety of B/F/TAF versus other antiretroviral therapy regimens for treatment-experienced people with HIV-1: a systematic literature review and network meta-analysis
Tristan Curteis, Lucy A Eddowes, Andrei Karlsson, et al.
Pharmacotherapy
|
July 15, 2024
Consensus recommendations for use of long-acting antiretroviral medications in the treatment and prevention of HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases Pharmacists
Elizabeth M Sherman, Allison L Agwu, Juan Ambrosioni, et al.
Pharmacotherapy
|
July 15, 2024
Consensus recommendations for use of long-acting antiretroviral medications in the treatment and prevention of HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases Pharmacists: An executive summary
Elizabeth M Sherman, Allison L Agwu, Juan Ambrosioni, et al.
Page
of 3